Introduction
============

Purple urine bag syndrome (PUBS) is an uncommon condition that occurs in urinary catheterized patients with urinary tract infection (UTI). It was first described in 1978, though a possible mechanism was not established until 1988 ([@b1-br-0-0-1046],[@b2-br-0-0-1046]). With regard to the mechanism, tryptophan is metabolized by intestinal bacteria, after which the by-product indoxyl sulfate is expelled into the urine and digested into indoxyl by sulfatases/phosphatases produced by certain bacteria including *Escherichia coli (E. coli), Proteus mirabilis, Morganella morganii (M. morganii), Klebsiella pneumoniae, Providencia stuartii, Providencia rettgeri* and *Pseudomonas aeruginosa* ([@b2-br-0-0-1046],[@b3-br-0-0-1046]). This indoxyl may convert into indigo and indirubin in the urine drainage bag and create purple discoloration ([@b2-br-0-0-1046]).

A higher prevalence of PUBS has been reported in females and in patients with alkaline urine, an indwelling urinary catheter and constipation ([@b3-br-0-0-1046]). The majority of patients with PUBS are catheterized due to significant disability, typically being chair-bound or bed-bound elderly patients ([@b3-br-0-0-1046]). In previous years, PUBS has been considered to be a benign syndrome rather than a disease with lethal potential, and appropriate empirical oral antibiotics including ciprofloxacin remain to be suggested for its treatment ([@b3-br-0-0-1046]). To the best of our knowledge, there have been no previous studies on the clinicopathological or epidemiological trends of PUBS; therefore, the current study retrospectively reviewed PUBS cases for characteristic analysis. A systematic review of PUBS cases reported between October 1980 and August 2016 was conducted, in which data regarding patient age and gender, comorbidities (diabetes mellitus, uremia, constipation and residence in long-term care facility), vital signs (presence or absence of fever), laboratory tests results \[seral white blood cell (WBC) count, urine pH value\] and mortality were evaluated. This aimed to identify trends in the epidemiology of PUBS. Through the systematic approach, the different clinicopathological aspects and general trends of PUBS were determined.

Materials and methods
=====================

### Search strategy and article selection

A systematic review was designed to investigate clinicopathological characteristics in PUBS, including patient age and gender, urine pH value, presence of fever, shock (defined by hypotension), WBC count, constipation and comorbidities (diabetes mellitus, uremia), urine culture bacteriology, rates of patients in long-term care units and mortality. To determine the trends in the epidemiology of PUBS, the differences in these characteristics over three decades were also analyzed. A search was performed for articles in the PubMed database (<https://www.ncbi.nlm.nih.gov/pubmed/>) including the word 'purple urine bag syndrome' in the title, published in the period from January 1, 1980 to September 1, 2016. A total 106 relevant articles were identified. Of these, 33 articles were excluded owing to ineligibility or lack of essential information. The full exclusion criteria are depicted in ([Fig. 1](#f1-br-0-0-1046){ref-type="fig"}). Therefore, 71 articles with patient data on 116 cases ([@b4-br-0-0-1046]--[@b74-br-0-0-1046]) were collected for review ([Table I](#tI-br-0-0-1046){ref-type="table"}). The articles were divided into three groups by publication year: 1991 to 2000, 2001 to 2010 and 2011 to 2016. The following clinical features were defined as: i) Elderly patients: age ≥65 years old; ii) fever: body temperature ≥38°C; iii) hypotension: systolic blood pressure \<90 mmHg or diastolic blood pressure \<60 mmHg.

### Statistical analysis

The data was analyzed with SPSS statistical software for Windows, version 11.5 (SPSS Inc., Chicago, IL, USA). Values are presented as the mean ± standard deviation. Statistical χ^2^ tests were performed and the threshold for significance was set at P\<0.05 (two-tailed).

Results
=======

### Description of the selected articles

In the present study, 106 relevant articles were retrieved. Following application of the inclusion and exclusion criteria, 71 eligible articles ([@b4-br-0-0-1046]--[@b74-br-0-0-1046]) were selected (57 in English, 4 in French, 3 in Spanish, 3 in Japanese, 1 in Chinese, 1 in German, 1 in Icelandic and 1 in Czech; [Fig. 1](#f1-br-0-0-1046){ref-type="fig"} and [Table I](#tI-br-0-0-1046){ref-type="table"}). All the selected articles were images in clinical medicine, individual case reports or serial case reports. The 71 articles included a total of 116 PUBS cases aged from 36 to 100 years old with a mean age ± standard deviation of 75.6±12.8 years. Of these, 47 cases were male (40.5%) and 69 were female (59.5%). Of these, 98 cases (84.5%) were elderly (≥65 years old).

### Clinical characteristics in PUBS

The mean age of the patients was 75.6 years old, and PUBS was more commonly observed in females than in males (1.5:1 ratio). As PUBS is associated with infectious pathology, mean WBC was determined for the cases, which was elevated to 12,242 cells/µl. Only 11.8% of cases presented with fever, and 8.6% of cases with shock. There were 6.9% of cases with acidic urine (pH\<7), while the remaining cases (93.1%) had urine pH\>7. The majority of cases (69.8%) had constipation, and 58.3% lived in long-term care units. Regarding chronic co-morbidity, 19.2% of cases had diabetes mellitus and 18.8% were uremic patients. Overall mortality rate was 6.8%, thus indicating that PUBS may be associated with patients\' mortality and not always a benign process.

### Clinical characteristics in trend per decade of PUBS cases

Regarding patient age, urine pH value, the presence of fever, shock or uremia, a history of diabetes, and residence in a long-term care unit, there were no significant changes over subsequent decades among the PUBS cases ([Table II](#tII-br-0-0-1046){ref-type="table"}). However, an increase in WBC count from 2001--2010 to 2011--2016 (P=0.002; [Table II](#tII-br-0-0-1046){ref-type="table"}), and in the male: female ratio with each decade (P=0.018; [Table I](#tI-br-0-0-1046){ref-type="table"} and [Fig. 2](#f2-br-0-0-1046){ref-type="fig"}) were identified. Notably, WBC count reached 17,060±14,480 cells/µl in the most recent five years. Conversely, decreases in constipation rates (P=0.011; [Table II](#tII-br-0-0-1046){ref-type="table"}) and mortality rates (P=0.001; [Table II](#tII-br-0-0-1046){ref-type="table"} and [Fig. 3](#f3-br-0-0-1046){ref-type="fig"}) were also identified over the subsequent decades. These decreasing rates may be attributed to advancements in antibiotic treatment and the application of early goal-directed-therapy (EGDT).

### Bacteriology statistics

Bacterial species identified in urine cultures of the PUBS patients are listed in [Table II](#tII-br-0-0-1046){ref-type="table"}. Culture results were not available for 9 cases, and there was no bacteria growth for 2 cases. Among the 105 patients with positive results, 3 patients yielded unidentified mixed organisms. The top five most common bacterial species identified were *E. coli*., *Enterococcus spp., Proteus spp., M. morganii* and *Klebsiella spp*.

Discussion
==========

It is well established that urinary tract infection (UTI) may occur at variable ages, while PUBS is commonly observed in elderly compared with non-elderly patients ([@b3-br-0-0-1046]), as in the present report (84.5 vs. 15.5%). As we know, PUBS can be observed in sepsis of asymptomatic bacteriuria (ABU) or CA-UTI.

The mechanism of PUBS originates from the dietary digestion and absorption of tryptophan in the bowel. Bacteria in the intestine metabolize the tryptophan to indole, and further hepatic enzymes form the conjugate indoxyl sulfate for secretion into urine by the kidneys. In the urinary tract, gram-negative bacteria phosphatases and sulfatases metabolize the indoxyl sulfate to indoxyl, and through oxidation, this may convert to indigo and indirubin ([@b2-br-0-0-1046]). For patients with indwelling catheters, blue indigo deposited on the urine drainage bag surface and red indirubin dissolved in the urine mixes into a purple discoloration ([@b2-br-0-0-1046]). A previous study demonstrated that not all bacterial organisms of the same species produce the phosphatase and sulfatase enzymes ([@b2-br-0-0-1046]). Based on the above mechanism, bacteriuria should be present in all patients with PUBS, which should be diagnosed as ABU for those without clinical symptoms or signs including fever or shock. A case control study reported that bacterial counts in urine were significantly higher (by 1 to 2 logs) in patients with PUBS compared with those without the syndrome, thus suggesting that a higher bacterial load in the urine is an important factor leading to PUBS ([@b75-br-0-0-1046]).

Regarding gender, females are generally more vulnerable to UTI and PUBS, and female gender has been previously considered a risk factor of catheter-associated (CA)-UTI among urinary catheterized patients ([@b76-br-0-0-1046],[@b77-br-0-0-1046]). In the present study, the number of PUBS cases became equal between the genders within the most recent 5 years. A similar finding was observed in a recent prospective observational study performed between November 2011 and October 2013 ([@b78-br-0-0-1046]). This study analyzed the incidence of healthcare-associated urinary tract infections in patients admitted to the urology ward of University Hospital 12 de Octubre in Spain with an indwelling urinary catheter. The incidence of CA-UTI in males vs. females was 8.22 vs. 8.46% without significant difference ([@b78-br-0-0-1046]). The study also analyzed the four most frequently cultured bacteria species in CA-UTI (*E. coli, Enterococcus, Klebsiella, Pseudomonas*) and identified no significant difference between genders. The diversities in the results of these studies results may be affected by other unidentified factors, including urinary catheter management or personal hygiene influence.

In accordance with PUBS being associated with infectious pathology of the urinary tract, the mean WBC count of all reviewed cases was elevated to 12,242/µl. Furthermore, WBC count significantly increased with time between 2001--2010 and 2011--2016.

There were 11.8% of PUBS cases presenting with fever and 8.6% of cases presenting with hypotension without significant difference between the decades. A total of 58.3% of subjects lived in long-term care units, and 19.2% had a history of diabetes. Urine pH value was the most stationary variable in each decade, varying between 8.0 and 8.1, which is compatible with the recognized conclusion from studies on PUBS: That PUBS more readily occurs in alkaline over acidic urine ([@b2-br-0-0-1046]--[@b4-br-0-0-1046]).

A small cohort study of Taiwanese patients demonstrated chronic kidney disease (CKD) to be a risk factor for PUBS ([@b79-br-0-0-1046]). The serum and urine levels of indoxyl sulfate are increased markedly in patients with chronic kidney disease or in those undergoing dialysis due to impaired renal clearance ([@b80-br-0-0-1046]). In the present study, 18.8% of PUBS cases had a history of uremia. Previous studies have also indicated comorbid conditions including diabetes mellitus, dementia and iron deficiency anemia are independent risk factors for ABU and UTI ([@b80-br-0-0-1046],[@b81-br-0-0-1046]).

It has previously been concluded there is an association of CA-UTI with increased mortality rate and prolonged length of stay in acute care facilities ([@b82-br-0-0-1046]). Furthermore, for PUBS involving Fournier\'s gangrene in immunosuppressed patients, the morbidity and mortality rates were increased ([@b30-br-0-0-1046]). Nevertheless, in uremic patients with PUBS, the elimination of indoxyl sulfate during dialysis is limited as it is bound to albumin, leading to exponential increase in serum indoxyl sulfate concentration. When treating patients with CKD and PUBS, clinicians should consider the elevated serum and urinary concentration of indoxyl sulfate due to its potential role in the progression of CKD, as well as its contribution to cardiovascular events ([@b57-br-0-0-1046]).

Constipation is considered to be a predisposing factor in PUBS due to the increased time it elicits for bacterial deamination. In the present study, constipation rate significantly decreased after 2001, though this may have been an artifact based on the relatively small number of cases reported in the decade of 1991--2000.

Overall mortality rate was 6.8%, thus indicating that PUBS is not always a benign process. However, mortality rate declined with time over the three decades, concordant with the introduction of EGDT for severe sepsis in 2001 ([@b83-br-0-0-1046]). Therefore, this progress may be attributed to the new recommendation of EGDT, which may achieve aggressive correction of septic shock when combined with early appropriate antibiotic administration. Nonetheless, the mortality rate of patients with severe sepsis declined following the implementation of EGDT ([@b84-br-0-0-1046]--[@b87-br-0-0-1046]). A recent meta-analysis study also concluded that important factors contributing to improved outcome are time-to-first antibiotic administration and appropriate antibiotic use ([@b88-br-0-0-1046]).

In conclusion, the ratio of males: females with PUBS increased over recent decades. Therefore, the urine color in catheterized patients should be monitored not only in female but also male patients. PUBS may not always be a benign process, and emphasis is required on early examination and aggressive antibiotic administration. Although WBC count was elevated over the recent decades, the morality rate was lowest in the most recent five years and decreased by decade; the overall mortality rate was 6.8%, and lowered to 4.3% in the last five years.

This was a case-controlled study that searched relevant articles in the PubMed database. A limitation of this may have been the exclusion of cases based on inadequate information, leading to bias and introducing confounding factors. Furthermore, the relatively small number of PUBS studies in each decade may have limited the accuracy of statistical analyses. There may also be cases of PUBS unreported in the PubMed database which were unaccounted for.
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###### 

Case demongraphics of the 71 articles included in the present study.

  Author                      Year   Language    Country          Cases                                            Mean age ± SD (years old)   Refs.
  --------------------------- ------ ----------- ---------------- ------------------------------------------------ --------------------------- ----------------------
  Umeki                       1993   Japanese    Japan            4                                                80±1.41                     ([@b4-br-0-0-1046])
  Nobukuni *et al*            1995   Japanese    Japan            5                                                60.4±10.61                  ([@b5-br-0-0-1046])
  Al-Jubouri and Vardhan      2001   English     UK               1                                                85                          ([@b6-br-0-0-1046])
  Ihama and Hokama            2002   English     Japan            1                                                93                          ([@b7-br-0-0-1046])
  Vallejo-Manzur *et al*      2005   English     USA              1                                                72                          ([@b9-br-0-0-1046])
  Wang *et al*                2005   English     Taiwan           2^[a](#tfn1-br-0-0-1046){ref-type="table-fn"}^   61                          ([@b10-br-0-0-1046])
  Rohaut *et al*              2005   French      France           1                                                81                          ([@b8-br-0-0-1046])
  Achtergael *et al*          2006   English     Belgium          1                                                77                          ([@b11-br-0-0-1046])
  Beunk *et al*               2006   English     UK               1                                                84                          ([@b12-br-0-0-1046])
  Tang                        2006   English     Hong Kong        2                                                76±8.49                     ([@b13-br-0-0-1046])
  Su *et al*                  2007   English     Taiwan           1                                                61                          ([@b20-br-0-0-1046])
  Nair *et al*                2007   English     UK               1                                                83                          ([@b18-br-0-0-1046])
  Bar-Or *et al*              2007   English     USA              1                                                68                          ([@b14-br-0-0-1046])
  Gautam *et al*              2007   English     India            1                                                70                          ([@b15-br-0-0-1046])
  Ting *et al*                2007   English     Taiwan           1                                                72                          ([@b21-br-0-0-1046])
  Lazimy *et al*              2007   French      France           1                                                74                          ([@b17-br-0-0-1046])
  Harun *et al*               2007   English     Brunei           2                                                60±21.21                    ([@b16-br-0-0-1046])
  Pillai *et al*              2007   English     UK               1                                                76                          ([@b19-br-0-0-1046])
  Lin *et al*                 2008   English     Taiwan           10                                               75.3±2.12                   ([@b24-br-0-0-1046])
  Chiang *et al*              2008   Chinese     Taiwan           1                                                73                          ([@b22-br-0-0-1046])
  Chung *et al*               2008   English     Taiwan           1                                                85                          ([@b23-br-0-0-1046])
  Vidarsdottir *et al*        2008   Icelandic   Iceland          1                                                72                          ([@b27-br-0-0-1046])
  Shiao *et al*               2008   English     Taiwan           14                                               80.9±11.5                   ([@b26-br-0-0-1046])
  Muneoka *et al*             2008   Japanese    Japan            6                                                87.7±16.26                  ([@b25-br-0-0-1046])
  Tasi *et al*                2009   English     Taiwan           2                                                64±19.8                     ([@b30-br-0-0-1046])
  Al-Sardar and Haroon        2009   English     UK               1                                                82                          ([@b28-br-0-0-1046])
  Wu *et al*                  2009   English     Taiwan           1                                                95                          ([@b32-br-0-0-1046])
  van Iersel and Mattijssen   2009   English     Netherlands      1                                                72                          ([@b31-br-0-0-1046])
  Pillai *et al*              2009   English     Singapore        1                                                69                          ([@b29-br-0-0-1046])
  Ferrara *et al*             2010   English     Italy            1                                                81                          ([@b33-br-0-0-1046])
  Hirzallah and D\'Souza      2010   English     Jordan           1                                                78                          ([@b34-br-0-0-1046])
  Siu and Watanabe            2010   English     USA              1                                                48                          ([@b35-br-0-0-1046])
  Su *et al*                  2010   English     Taiwan           1                                                81                          ([@b36-br-0-0-1046])
  Kang *et al*                2011   English     Korea            3                                                74.7±0                      ([@b37-br-0-0-1046])
  Keenan and Thompson         2011   English     USA              1                                                97                          ([@b38-br-0-0-1046])
  Khan *et al*                2011   English     USA              1                                                39                          ([@b39-br-0-0-1046])
  Peters *et al*              2011   English     Australia        1                                                82                          ([@b40-br-0-0-1046])
  Zeier *et al*               2011   English     Singapore        1                                                75                          ([@b41-br-0-0-1046])
  Bocrie *et al*              2012   English     France           1                                                87                          ([@b42-br-0-0-1046])
  Cantaloube *et al*          2012   French      France           2                                                81.5±0.71                   ([@b43-br-0-0-1046])
  Dominguez Alegria *et al*   2012   Spanish     Spain            1                                                78                          ([@b44-br-0-0-1046])
  Meekins *et al*             2012   English     USA              1                                                67                          ([@b45-br-0-0-1046])
  Montasir and Mustaque       2013   English     Bangladesh       1                                                86                          ([@b46-br-0-0-1046])
  Bhattarai *et al*           2013   English     USA              1                                                87                          ([@b47-br-0-0-1046])
  Canavese *et al*            2013   English     Italy            3                                                79±19.52                    ([@b48-br-0-0-1046])
  Duff                        2013   English     USA              1                                                57                          ([@b49-br-0-0-1046])
  Iglesias Barreira *et al*   2013   Spanish     Spain            2                                                93.5±2.12                   ([@b50-br-0-0-1046])
  Mohamad and Chong           2013   English     Brunei           1                                                78                          ([@b51-br-0-0-1046])
  Ungprasert *et al*          2013   English     USA              1                                                44                          ([@b52-br-0-0-1046])
  Wolff *et al*               2013   French      France           1                                                90                          ([@b53-br-0-0-1046])
  Yaqub *et al*               2013   English     Pakistan         1                                                83                          ([@b54-br-0-0-1046])
  Agapakis *et al*            2014   English     Greece           1                                                82                          ([@b55-br-0-0-1046])
  Chassin-Trubert *et al*     2014   Spanish     Chile            1                                                72                          ([@b56-br-0-0-1046])
  Delgado *et al*             2014   English     Mexico           1                                                60                          ([@b57-br-0-0-1046])
  Hloch *et al*               2014   Czech       Czech Republic   1                                                73                          ([@b58-br-0-0-1046])
  Restuccia and Blasi         2014   English     Italy            1                                                81                          ([@b59-br-0-0-1046])
  Sheehan                     2014   English     USA              1                                                80                          ([@b60-br-0-0-1046])
  Abubacker *et al*           2015   English     India            1                                                36                          ([@b61-br-0-0-1046])
  Alex *et al*                2015   English     India            1                                                83                          ([@b62-br-0-0-1046])
  Karim *et al*               2015   English     USA              1                                                83                          ([@b63-br-0-0-1046])
  Kenzaka                     2015   English     Japan            1                                                72                          ([@b64-br-0-0-1046])
  Mohamed Faisal *et al*      2015   English     Malaysia         1                                                68                          ([@b65-br-0-0-1046])
  Mondragon-Cardona *et al*   2015   English     Colombia         1                                                71                          ([@b66-br-0-0-1046])
  Neweling and Janssens       2015   German      Germany          1                                                78                          ([@b67-br-0-0-1046])
  Redwood *et al*             2015   English     USA              1                                                90                          ([@b68-br-0-0-1046])
  Van Keer *et al*            2015   English     Belgium          2                                                80.5±0.71                   ([@b69-br-0-0-1046])
  Demelo-Rodriguez *et al*    2016   English     Spain            1                                                83                          ([@b70-br-0-0-1046])
  Faridi *et al*              2016   English     India            1                                                76                          ([@b71-br-0-0-1046])
  Richardson-May              2016   English     UK               1                                                94                          ([@b72-br-0-0-1046])
  Sriramnaveen *et al*        2016   English     India            1                                                85                          ([@b73-br-0-0-1046])
  Tul Llah *et al*            2016   English     USA              1                                                52                          ([@b74-br-0-0-1046])

The same patient with two purple urine bag syndrome episodes. SD, standard deviation.

###### 

Comparisons of purple urine bag syndrome cases (n=116) over the last three decades.

                                                      Decade, mean±SD or % (total cases, n)                                                   
  -------------------------- ------------------------ --------------------------------------- ---------------------- ------------------------ -------
  Age                        75.6±12.8 (116)          69.1±13.1 (9)                           75.9±11.3 (59)         75.8±16.8 (48)           0.857
  Mean WBC count, cells/µl   12,242.7±10,661.5 (27)   NA                                      9,203.3±3,736.7 (15)   17,060.0±14,480.4 (12)   0.002
  Urine pH value             8.0±0.9 (72)             8.1±0.7 (6)                             8.0±0.9 (36)           8.0±1.1 (30)             0.368
  Male: female               47:69 (116)              2:7 (9)                                 22:39 (61)             23:23 (46)               0.018
  Fever                      12.1 (14/116)            22.2 (2/9)                              9.8 (6/61)             13.0 (6/46)              0.360
  Shock                      8.6 (10/116)             0.0 (0/9)                               9.8 (6/61)             8.7 (4/46)               0.418
  Constipation               69.8 (44/63)             100.0 (4/4)                             68.4 (26/38)           66.7 (14/21)             0.011
  Diabetes mellitus          19.2 (19/99)             11.1 (1/9)                              25.6 (11/43)           14.9 (7/47)              0.266
  Uremia                     18.8 (21/112)            11.1 (1/9)                              20.0 (12/60)           18.6 (8/43)              0.267
  Long-term care unit        58.3 (35/60)             NA                                      60.0 (27/45)           53.3 (8/15)              0.057
  Mortality                  6.8 (8/116)              11.1 (1/9)                              8.2 (5/61)             4.3 (2/46)               0.001

WBC, white blood cell; NA, not available; SD, standard deviation.

###### 

Urine culture data of purple urine bag syndrome patients.

  Bacteria                         Cases, n   \%
  -------------------------------- ---------- -------
  *Escherichia coli*               41         23.0
  *Polymicrobial*                  36         20.2
  *Enterococcus spp*               22         12.4
  *Proteus spp*                    16         9.0
  *Morganella morganii*            15         8.4
  *Klebsiella spp*                 15         8.4
  *Providencia rettgeri*           13         7.3
  *Pseudomonas aeruginosa*         11         6.2
  *Streptococcus spp*              4          2.2
  *Unidentified mixed organisms*   3          1.7
  *Staphylococcus spp*             2          1.1
  *Total*                          142        100.0

Polymicrobial indicates ≥2 bacterial species.
